A hypothalamic digoxin-mediated model for autism

International Journal of Neuroscience

Volumn 113, Issue 11, 2003, Pages 1537-1559

  Kurup, Ravi Kumar ^a   Kurup, Parameswara Achutha ^b,c  

^a Medical College Hospital Thiruvananthapuram   (India)

^b Metabolic Disorders Research Center   (India)

^c NONE   (India)

Author keywords

Autism; Digoxin; Dolichol; Ubiquinone

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM) INHIBITOR; ANTIGEN; CALCIUM; DIGOXIN; DOLICHOL; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; FREE RADICAL; GLYCINE RECEPTOR ANTAGONIST; GLYCOCONJUGATE; GLYCOSAMINOGLYCAN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; ISOPRENOID; LYSOSOME ENZYME; MAGNESIUM; MEMBRANE ENZYME; MORPHINE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; NEURONAL ANTIGEN; NICOTINE; NORADRENALIN; QUINOLINIC ACID; SEROTONIN; STRYCHNINE; TRYPTOPHAN; TYROSINE; UBIQUINONE; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ADOLESCENT; AMINO ACID TRANSPORT; ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; AUTISM; AUTOIMMUNITY; CALCIUM CELL LEVEL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIGOXIN BLOOD LEVEL; DISEASE MODEL; DISEASE PREDISPOSITION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; ENZYME ACTIVITY; ENZYME INHIBITION; ERYTHROCYTE MEMBRANE; EXCITOTOXICITY; HEMISPHERIC CHEMICAL DOMINANCE; HEMISPHERIC DOMINANCE; HUMAN; HYPERPOLARIZATION; HYPOMAGNESEMIA; HYPOTHALAMUS; IMMUNOSTIMULATION; LIMBIC CORTEX; MALE; METABOLISM; METABOLITE; NEUROCHEMISTRY; NEUROMODULATION; NEUROPATHOLOGY; NEUROTOXICITY; PERCEPTION; PERSISTENT VIRUS INFECTION; SYNAPTOGENESIS;

ADOLESCENT; AUTISTIC DISORDER; CHILD; DIGOXIN; DOLICHOL; FEMALE; HUMANS; HYPOTHALAMUS; MAGNESIUM; MALE; NA(+)-K(+)-EXCHANGING ATPASE; TRYPTOPHAN; TYROSINE; UBIQUINONE;

EID: 0242485408     PISSN: 00207454     EISSN: None     Source Type: Journal    
DOI: 10.1080/00207450390231482     Document Type: Article

References (54)

1. Andreasen, N. C. (1992). Linking mind and brain in the study of mental illnesses: A project for a scientific psychopathology. Science, 275, 1586-1590.
2. Arun, P., Ravikumar, A., Leelamma, S., & Kurup, P. A. (1998a). Identification and estimation of endogenous EDLF in biological fluids and tissues by TLC and HPLC. Indian Journal of Biochemistry & Biophysics, 35, 308-312.
3. Arun, P., Ravikumar, A., Leelamma, S., & Kurup, P. A. (1998b). Endogenous alkaloids in the brain of rats loaded with tyrosine/tryptophan and in the serum of patients of neurodegenerative and psychiatric disorders. Indian Journal of Medical Research, 197, 231-238.
4. Ashkenazi, A., & Dixit, V. M. (1998). Death receptors signalling and modulation. Science, 281, 1305-1308.
5. Beal, F. (1992). Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative disease. Annals of Neurology, 31, 119-130.
6. Beutler, E., Duran, O., & Kelley, B. M. (1963). Modified procedure for the estimation of reduced glutathione. Journal of Laboratory & Clinical Medicine, 61, 882.
7. Bloxam, L. D., & Warren, W. H. (1974). Error in the determination of tryptophan by the method of Denkala and Dewey. A revised procedure. Analytical Biochemistry, 60, 621-625.
8. Brien, P. J. O. (1969). Estimation of conjugated dienes and hydroperoxide. Canadian Journal of Biochemistry, 47, 485.
9. Brown, P. (1994). Understanding the inner voices. New Scientists, 2, 26-32.
10. Camili, P. D. (1995). Neurotransmission keeping synapses up to speed. Nature, 375, 450-451.
11. Carpenter, W. T., Jr., & Buchanan, R. W. (1994). Medical progress in schizophrenia. New England Journal of Medicine, 30(10), 681-690.
12. Christo, D. J., & EI Mallakh, R. S. (1993). Possible role of endogenous ouabain like compounds in the pathophysiology of bipolar illness. Medical Hypothesis, 41(4), 378.
13. Crick, F. (1994). The astonishing hypothesis-The scientific search for the human soul. New York: Charles Scribners Sons.
14. Curzon, G., & Green, A. R. (1970). Rapid method for the determination of 5-hydroxy tryptophan and 5-hydroxy indoleacetic acid in certain regions of rat brain. British Journal of Pharmacology, 39, 653-655.
15. Donnerer, J., Oka, K., Brossi, R., Rice, K. C., & Spector, S. (1986). Presence and formation of codeine and morphine in the rat. Proceedings of National Academy of Science USA, 83, 4566-4567.
16. Finkel, T. B. (1991). T-cell development and transmembrane signalling. Changing biological responses through an unchanging receptor. Immunology Today, 12, 79-86.
17. Freese, B. A., Swartz, K. J., During, M. J., & Martin, J. B. (1990). Kynurenine metabolites of tryptophan. Implication for neurological diseases. Neurology, 40, 691-695.
18. Gabor, G., & Allon, N. (1994). Spectrofluorometric method for NO determination. Analytical Biochemistry, 220, 16-20.
19. Goldstein, J. L., & Brown, M. S. (1990). Regulation of the mevalonate pathway. Nature, 343, 425-430.
20. ++ accumulation in rat striatum and substantia nigra after and intrastriatal injection of quinolinic acid. Experimental Neurology, 121(2), 261-269.
21. Green, D. R., & Reed, J. C. (1988). Mitochondria and apoptosis. Science, 281, 1309-1316.
22. Greenamyre, J. T., & Poter, R. H. P. (1994). Anatomy and physiology of glutamate in CNS. Neurology, 44(8), S7-S13.
23. ++ supplementation on diumal variation of BP and plasma Na+-K+ ATPase activity in essential hypertension. Japanese Heart Journal, 33(6), 785-798.
24. Haupert, G. T. (1989). Sodium pump regulation by endogenous inhibition. Topics in Membrane Transport, 34, 345-348.
25. Hisaka, A., Kasamatu, S., & Takenaga, N. (1990). Absorption of a novel prodrug of DOPA. Drug-Metabolism Disposal, 18, 621-625.
26. Horn, H. D., & Burns, F. H. (1978). Methods of enzymatic analysis. New York: Academic Press.
27. 10 level in schizophrenia patients. Neurology, 43(2), 143.
28. Ishimaru, M., Kurumajii, A., & Toru, M. (1994). Increases in strychnine-insensitive glycine binding sites in cerebral cortex of chronic schizophrenics: Evidence for glutamate hypothesis. Biological Psychiatry, 35(2), 84.
29. Jakob, H., & Beckmann, H. (1986). Prenatal developmental disturbance in the limbic allocortex in schizophrenics. Journal of Neural Transmission, 65, 303-315.
30. Jaya, P., & Kurup, P. A. (1986). Effect of magnesium deficiency on the metabolism of glycosaminoglycans in rats. Journal of Bioscience, 10, 487-497.
31. Jyothi, A. (1998). Investigations on metabolic derangement in coronary artery disease and neurodegenerative disorders. Trivandrum: University of Kerala Press.
32. Kakkar, P., Das, B., & Viswanathan, P. N. (1984). A modified spectrophotometric assay of SOD. Indian Journal of Biochemistry & Biophysics, 21, 130-135.
33. Kinney, H. C., & Samuels, M. A. (1994). Neuropathology of the persistent vegetative state. Journal of Neuropathology, 53(6), 458-548.
34. Linstinsky, J. L., Siegal, G. P., & Listinsky, C. M. (1998). Alpha-L-fucose a potentially critical molecule in pathologic process including neoplasia. American Journal of Clinical Pathology, 110, 425-440.
35. Lockwood, M. (1989). Mind, brain and quantum: The compound "I". London: Blackwell Publications.
36. Lowenstein, J. M. (1969). Methods in enzymology (25). New York: Academic Press.
37. Maehly, A. C., & Chance, B. (1954). The assay of catalase and peroxidase. Methods of Biochemical Analysis, 2, 357-362.
38. Manoj, A. J., & Kurup, P. A. (1998). Changes in the glycosaminoglycans and glycoproteins in the rat brain during protein calorie malnutrition. Clinical Biochemistry & Nutrition, 25, 149-157.
39. Miles, R., & Wong, R. K. S. (1983). Single neuron can initiate synchronized population discharges in hippocampus. Nature, 306, 371-373.
40. Monia, B. P., Ecker, J., & Crooke, S. T. (1990). Ubiquitination enzymes. Biotechnology, 8, 209-215.
41. Paglia, D. E., & Valentine, W. N. (1967). Studies on quantitative and qualitative characterisation of erythrocyte glutathione peroxidase. Journal of Laboratory & Clinical Medicine, 70, 158-162.
42. Palmer, D. N., Maureen, A. A., & Robert, D. J. (1984). Separation of some neutral lipids by normal phase high performance liquid chromatography on a cyanopropyl column: Ubiquinone, dolichol and cholesterol levels in sheep liver. Analytical Biochemistry, 140, 315-319.
43. Ploegh, H. L. (1998). Viral strategies for immune evasion. Science, 280(10), 248-253.
44. Price, W. J. (1985). Spectrochemical analysis by atomic absorption. New York: John Wiley Sons.
45. Rao, A. V., & Ramakrishnan, S. (1975). Estimation of HMG CoA reductase activity. Clinical Chemistry, 21, 1523-1528.
46. Reynolds, J. N., Baskys, A., & Carlen, P. L. (1987). Serotonin enhances responses to N-methyl-D-asparate in rat neocortical neurons. 17th Annual Meeting Society of Neuroscience Abstract, 433, 11-12.
47. Seiden, S. L., & Dykstra, A. L. (1977). Psychopharmacology-a biochemical and behavioural approach. New York: Van Nostrand Reinhold Company.
48. Slegel, R. A. (1998). A lesson from secretory granules. Nature, 394, 428-429.
49. Wallach, D. F. H., & Kamath, V. B. (1966). Methods in enzymology (8). New York: Academic Press.
50. Well-Malherbe, R. (1971). Methods of biochemical analysis. New York: Inter Science
51. Wiedemann, C., & Cockcroft, S. (1998). Vesicular transport. Nature, 394, 426-428.
52. Will, E. D. (1969). Lipid peroxide formation in microsomes-general consideration. Biochemical Journal, 113, 315-320.
53. Wong, P. W. K., O'Flynn, M. E., & Inouye, R. (1964). Flourimetric method for tyrosine. Clinical Chemistry, 10, 1098-1100.
54. Yu, Z. J., & Wecker, L. (1994). Chronic nicotine administration differentially affects neurotransmitter release from rat striatal slices. Journal of Neurochemistry, 63, 186-194.